Targeting P13K/AKT-dependent cellular senescence to treat cancer

Lead researcher

Prof Richard Pearson, Dr Katherine Hannan

Institution

The University of Melbourne

Years funded

2014-2016

This project investigates new ways to arrest the growth of cancer cells by re-activating a checkpoint that protects normal cells from becoming cancerous. It will lead to new treatments for a range of cancer types.

Lay Report

Funding Body

Cancer Council Research Grant

Funding

$100,000 per annum

Updated: